Back to top
more

Perrigo (PRGO)

(Delayed Data from NYSE)

$27.69 USD

27.69
1,056,559

-0.49 (-1.74%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $27.72 +0.03 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (86 out of 249)

Industry: Medical - Products

Better trading starts here.

Zacks News

PRGO vs. PAHC: Which Stock Should Value Investors Buy Now?

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results

Perrigo (PRGO) announces better-than-expected preliminary results for fourth-quarter 2019 as well as the full year. Shares gain.

Perrigo (PRGO) Up 4.1% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Perrigo (PRGO) Beats on Q3 Earnings, Tightens '19 EPS View

Perrigo (PRGO) reports mixed third-quarter 2019 results. The Rx segment continues to witness recovery. Stock down.

Perrigo (PRGO) Beats Q3 Earnings Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of 11.83% and -0.95%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be reported quarter.

Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trina Mukherjee headshot

Medical Products Industry Outlook: Prospects Seem Promising

Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.

Why Is Perrigo (PRGO) Up 6.1% Since Last Earnings Report?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRGO vs. BIO: Which Stock Is the Better Value Option?

PRGO vs. BIO: Which Stock Is the Better Value Option?

Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up

Perrigo (PRGO) reports encouraging second-quarter 2019 results. The Rx segment recovers on strong new product sales.

Perrigo (PRGO) Tops Q2 Earnings and Revenue Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of 6.17% and 1.58%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo (PRGO) is focused on Consumer Self Care Americas segment. It remains to be seen if this benefits the company's results in the soon-to-be reported quarter.

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRGO or SRDX: Which Is the Better Value Stock Right Now?

PRGO vs. SRDX: Which Stock Is the Better Value Option?

Perrigo Completes Ranir Acquisition, Raises '19 Guidance

Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.

Why Is Perrigo (PRGO) Down 17.4% Since Last Earnings Report?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up

Perrigo (PRGO) reports encouraging first-quarter 2019 results. The Rx segment recovers during the quarter on strong new product sales.

Perrigo (PRGO) Q1 Earnings and Revenues Top Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of 13.83% and 2.20%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo (PRGO) is focused on Consumer Healthcare Americas segment. Let's see if it aids the company's results in the soon-to-be reported quarter.

Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?

Strong performance across Renal Care, Clinical Nutrition, Advanced Surgery and Acute Therapies businesses might aid Baxter (BAX) in Q1. However, lower sales at Pharmaceutical business might be a woe.

Urmimala Biswas headshot

3 Medical Product Stocks Set to Beat This Earnings Season

The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

Perrigo (PRGO) Down 2.7% Since Last Earnings Report: Can It Rebound?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Perrigo (PRGO) Q4 Earnings Miss, Sales Beat, Stock Down

Perrigo (PRGO) reports wider loss in fourth-quarter 2018. However, sales were marginally higher. Challenges in the Rx segment continues to hurt the top line.

What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo (PRGO) is focused on Consumer Healthcare Americas segment. Let's see if it aids the company's results in the soon-to-be reported quarter.